{"denoms":[{"counts":[{"groupId":"BG000","value":"546"},{"groupId":"BG001","value":"542"},{"groupId":"BG002","value":"1088"}],"units":"Participants"}],"groups":[{"description":"Participants received 1000 milligram (mg) abiraterone acetate tablets (as 4\\*250 mg tablets) orally once daily along with prednisone 5 mg tablet orally twice daily, from Day 1, Cycle1 (each cycle consist of 28 days) up to radiographic progression of disease and/or unequivocal clinical progression.","id":"BG000","title":"Abiraterone Acetate + Prednisone (AAP)"},{"description":"Participants received placebo matched to abiraterone acetate tablets orally once daily along with prednisone 5 mg tablet orally twice daily, from Day 1, Cycle1 (each cycle consist of 28 days) up to radiographic progression of disease and/or unequivocal clinical progression.","id":"BG001","title":"Placebo"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.8","value":"70.5"},{"groupId":"BG001","spread":"8.72","value":"70.1"},{"groupId":"BG002","spread":"8.76","value":"70.3"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"546"},{"groupId":"BG001","value":"542"},{"groupId":"BG002","value":"1088"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"132"}]}],"title":"Australia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"42"}]}],"title":"Belgium"},{"categories":[{"measurements":[{"groupId":"BG000","value":"63"},{"groupId":"BG001","value":"37"},{"groupId":"BG002","value":"100"}]}],"title":"Canada"},{"categories":[{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"29"},{"groupId":"BG002","value":"53"}]}],"title":"France"},{"categories":[{"measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"32"},{"groupId":"BG002","value":"78"}]}],"title":"Germany"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"14"}]}],"title":"Greece"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"7"}]}],"title":"Italy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"30"}]}],"title":"Netherlands"},{"categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"45"}]}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"17"}]}],"title":"Sweden"},{"categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"56"},{"groupId":"BG002","value":"98"}]}],"title":"United Kingdom"},{"categories":[{"measurements":[{"groupId":"BG000","value":"234"},{"groupId":"BG001","value":"238"},{"groupId":"BG002","value":"472"}]}],"title":"United States"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"}]}